688366 昊海生科
已收盘 08-14 15:00:01
资讯
新帖
简况
股市必读:昊海生科新发布《H股公告:董事会会议召开日期》
证券之星 · 08-12 02:50
股市必读:昊海生科新发布《H股公告:董事会会议召开日期》
昊海生科(688366)披露董事会将审议2026年中期业绩及中期股息事项,8月11日股价下跌0.37%
证券之星 · 08-11 22:26
昊海生科(688366)披露董事会将审议2026年中期业绩及中期股息事项,8月11日股价下跌0.37%
每周股票复盘:昊海生科(688366)三焦点人工晶状体获注册证
证券之星 · 08-09
每周股票复盘:昊海生科(688366)三焦点人工晶状体获注册证
昊海生科最新公告:控股子公司三焦点环曲面人工晶状体获医疗器械注册证
证券之星 · 08-06
昊海生科最新公告:控股子公司三焦点环曲面人工晶状体获医疗器械注册证
昊海生科(688366)披露截至2026年7月31日股份变动月报表,8月4日股价上涨0.19%
证券之星 · 08-04
昊海生科(688366)披露截至2026年7月31日股份变动月报表,8月4日股价上涨0.19%
每周股票复盘:昊海生科(688366)两日购回H股合计23.4万股
证券之星 · 07-26
每周股票复盘:昊海生科(688366)两日购回H股合计23.4万股
昊海生科(688366)披露H股翌日披露报表,7月20日股价上涨2.25%
证券之星 · 07-20
昊海生科(688366)披露H股翌日披露报表,7月20日股价上涨2.25%
每周股票复盘:昊海生科(688366)回购注销114.87万股H股
证券之星 · 07-05
每周股票复盘:昊海生科(688366)回购注销114.87万股H股
昊海生科(688366)披露H股股份注销公告,7月3日股价上涨1.27%
证券之星 · 07-03
昊海生科(688366)披露H股股份注销公告,7月3日股价上涨1.27%
每周股票复盘:昊海生科(688366)注销114.87万股H股
证券之星 · 06-28
每周股票复盘:昊海生科(688366)注销114.87万股H股
昊海生科(688366)披露关于变更持续督导保荐代表人的公告,6月26日股价下跌3.57%
证券之星 · 06-26
昊海生科(688366)披露关于变更持续督导保荐代表人的公告,6月26日股价下跌3.57%
执行董事唐敏捷增持昊海生科(06826)5000股 每股作价16.12港元
智通财经网 · 06-17
执行董事唐敏捷增持昊海生科(06826)5000股 每股作价16.12港元
港股异动 | 昊海生科(06826)尾盘涨近3% 控股子公司三焦点人工晶状体产品获得医疗器械注册证
智通财经 · 06-04
港股异动 | 昊海生科(06826)尾盘涨近3% 控股子公司三焦点人工晶状体产品获得医疗器械注册证
昊海生科(688366.SH)控股子公司三焦点人工晶状体产品获得医疗器械注册证
智通财经 · 06-02
昊海生科(688366.SH)控股子公司三焦点人工晶状体产品获得医疗器械注册证
昊海生科(688366)披露因H股股份回购需通知债权人公告,6月1日股价上涨0.99%
证券之星 · 06-01
昊海生科(688366)披露因H股股份回购需通知债权人公告,6月1日股价上涨0.99%
昊海生科:侯永泰辞任执行董事、董事长
美股速递 · 05-29
昊海生科:侯永泰辞任执行董事、董事长
5月25日昊海生科发布公告,股东减持77.47万股
证券之星 · 05-25
5月25日昊海生科发布公告,股东减持77.47万股
每周股票复盘:昊海生科(688366)累计购回374.89万股H股
证券之星 · 05-17
每周股票复盘:昊海生科(688366)累计购回374.89万股H股
昊海生科(688366)披露H股股份购回进展,5月15日股价下跌1.07%
证券之星 · 05-15
昊海生科(688366)披露H股股份购回进展,5月15日股价下跌1.07%
昊海生科风波再起:实控人涉嫌内幕交易,业绩断崖式下滑
新浪证券 · 05-15
昊海生科风波再起:实控人涉嫌内幕交易,业绩断崖式下滑
加载更多
公司概况
公司名称:
上海昊海生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2019-10-30
主营业务:
上海昊海生物科技股份有限公司的主营业务是医疗器械和药品研发、生产和销售业务。公司的主要产品是医疗美容与创面护理产品、眼科产品、骨科关节腔粘弹补充剂产品、防粘连及止血产品。本集团的医用几丁糖专利技术先后获得“上海市技术发明一等奖”和“国家科学技术进步奖二等奖”,生产出国际上第一个成功应用于人体内的医用几丁糖产品;外用人表皮生长因子产品获得“国家科学技术进步奖二等奖”,是国际第一个获得注册的外用人表皮生长因子产品;本集团参与研发的“生物适配防粘连材料的关键技术及临床应用”项目获得上海市技术发明奖一等奖。
发行价格:
89.23
{"stockData":{"symbol":"688366","market":"SH","secType":"STK","nameCN":"昊海生科","latestPrice":32.73,"timestamp":1786690801000,"preClose":33.02,"halted":0,"volume":1150319,"delay":0,"changeRate":-0.0088,"floatShares":194000000,"shares":229000000,"eps":1.0237,"marketStatus":"已收盘","change":-0.29,"latestTime":"08-14 15:00:01","open":32.84,"high":33.75,"low":32.56,"amount":38066500,"amplitude":0.036,"askPrice":32.84,"askSize":11,"bidPrice":32.73,"bidSize":43,"shortable":0,"etf":0,"ttmEps":1.0237,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":5,"adr":0,"adjPreClose":33.02,"symbolType":"stock_kcb","openAndCloseTimeList":[[1786671000000,1786678200000],[1786683600000,1786690800000]],"highLimit":36.32,"lowLimit":29.72,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":228832195,"isCdr":false,"pbRate":1.38,"roa":"--","peRate":31.972257,"roe":"1.35%","epsLYR":1.08,"committee":0.406897,"marketValue":7490000000,"turnoverRate":0.0059,"status":1,"afterMarket":{"amount":0,"volume":0,"close":32.73,"buyVolume":0,"sellVolume":1000,"time":1786692837746,"indexStatus":"已收盘 08-14 15:30:00","preClose":33.02},"hkstockBrief":{"symbol":"06826","market":"HK","secType":"STK","nameCN":"昊海生物科技","latestPrice":16.75,"timestamp":1786694914833,"preClose":16.82,"halted":0,"volume":74600,"delay":0,"premium":"-56.02"},"floatMarketCap":6351000000},"requestUrl":"/m/hq/s/688366","defaultTab":"news","newsList":[{"id":"2658910589","title":"股市必读:昊海生科新发布《H股公告:董事会会议召开日期》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658910589","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658910589?lang=zh_cn&edition=full","pubTime":"2026-08-12 02:50","pubTimestamp":1786474218,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘,昊海生科报收于32.66元,下跌0.37%,换手率0.42%,成交量8216.0手,成交额2690.47万元。公司公告汇总:昊海生科董事会将于2026年8月21日召开会议,审议截至2026年6月30日止六个月的中期业绩,并考虑派发中期股息(如有)。交易信息汇总资金流向8月11日主力资金净流入25.5万元,占总成交额0.95%;游资资金净流入49.57万元,占总成交额1.84%;散户资金净流出75.07万元,占总成交额2.79%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200002439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688366","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658919586","title":"昊海生科(688366)披露董事会将审议2026年中期业绩及中期股息事项,8月11日股价下跌0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658919586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658919586?lang=zh_cn&edition=full","pubTime":"2026-08-11 22:26","pubTimestamp":1786458382,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘,昊海生科报收于32.66元,较前一交易日下跌0.37%,最新总市值为74.74亿元。该股当日开盘32.82元,最高33.28元,最低32.4元,成交额达2690.47万元,换手率为0.42%。近日,昊海生科发布H股公告披露,公司董事会将于2026年8月21日举行会议,审议公司及其附属公司截至2026年6月30日止六个月的中期业绩,并考虑派发中期股息(如有)。公告同时列出了董事会成员名单。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100038427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688366","BK0239","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658751186","title":"每周股票复盘:昊海生科(688366)三焦点人工晶状体获注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2658751186","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658751186?lang=zh_cn&edition=full","pubTime":"2026-08-09 03:00","pubTimestamp":1786215638,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,昊海生科报收于32.25元,较上周的31.73元上涨1.64%。本周,昊海生科8月7日盘中最高价报32.35元。上海昊海生物科技股份有限公司关于自愿披露控股子公司三焦点环曲面人工晶状体产品获得医疗器械注册证的公告控股子公司河南赛美视生物科技有限公司近日获得国家药品监督管理局颁发的三焦点环曲面人工晶状体产品医疗器械注册证。产品通过国家创新医疗器械特别审批程序,成为国内首款获批上市的国产三焦点散光人工晶状体。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688366","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657811266","title":"昊海生科最新公告:控股子公司三焦点环曲面人工晶状体获医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2657811266","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657811266?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:37","pubTimestamp":1786009043,"startTime":"0","endTime":"0","summary":"昊海生科(688366.SH)公告称,公司控股子公司河南赛美视生物科技有限公司近日收到国家药监局颁发的三焦点环曲面人工晶状体产品《医疗器械注册证》。该产品为国内首款获批上市的国产三焦点散光人工晶状体,适用于成人白内障合并角膜散光患者的视力矫正。此次获批进一步深化了公司在高端屈光性人工晶状体领域的布局,但该产品尚未形成销售,不会对公司近期业绩产生重大影响。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600029363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","09996","BK0251","BK0239","BK1583","BK1574","BK1100","688366"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656527025","title":"昊海生科(688366)披露截至2026年7月31日股份变动月报表,8月4日股价上涨0.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656527025","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656527025?lang=zh_cn&edition=full","pubTime":"2026-08-04 22:40","pubTimestamp":1785854427,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘,昊海生科报收于31.95元,较前一交易日上涨0.19%,最新总市值为73.11亿元。近日,昊海生科披露《截至二零二六年七月三十一日止月份股份发行人的证券变动月报表》。公告显示,截至2026年7月31日,公司H股已发行股份为34,780,340股,A股已发行股份为194,051,855股,其中A股包含3,848,095股库存股;公司H股和A股的法定/注册股本无变动。报告期内,公司于2026年5月29日购回234,000股H股,拟注销但截至月底尚未注销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400041708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0239","688366"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654057328","title":"每周股票复盘:昊海生科(688366)两日购回H股合计23.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654057328","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654057328?lang=zh_cn&edition=full","pubTime":"2026-07-26 02:23","pubTimestamp":1785003790,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,昊海生科报收于29.56元,较上周的31.98元下跌7.57%。本周,昊海生科7月21日盘中最高价报32.98元。本周关注点公司公告汇总:昊海生科连续两日披露H股购回,合计购回234,000股,总代价约386.5万港元。公司公告汇总上海昊海生物科技有限公司于2026年7月20日提交翌日披露报表,确认当日通过香港联合交易所购回H股161,000股,每股价格介乎16.14至16.85港元,总代价2,639,621港元。该等股份拟注销,不持有库存股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688366","BK0239","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652851214","title":"昊海生科(688366)披露H股翌日披露报表,7月20日股价上涨2.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652851214","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652851214?lang=zh_cn&edition=full","pubTime":"2026-07-20 22:39","pubTimestamp":1784558351,"startTime":"0","endTime":"0","summary":"截至2026年7月20日收盘,昊海生科报收于32.7元,较前一交易日上涨2.25%,最新总市值为74.83亿元。近日,昊海生科披露H股翌日披露报表。公告显示,公司于2026年7月20日通过香港联合交易所购回H股161,000股,每股价格介乎16.14至16.85港元,总代价2,639,621港元。该等股份拟注销,不持有库存股份。此次购回依据2026年5月29日通过的授权进行,占当时已发行股份的0.4629%,购回后30日内不会发行新股或出售库存股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000039901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688366","BK0251","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649692269","title":"每周股票复盘:昊海生科(688366)回购注销114.87万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649692269","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649692269?lang=zh_cn&edition=full","pubTime":"2026-07-05 04:21","pubTimestamp":1783196470,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,昊海生科报收于31.04元,较上周的28.61元上涨8.49%。本周,昊海生科7月2日盘中最高价报31.3元。本周关注点公司公告汇总:昊海生科以自有资金回购并注销1,148,700股H股,注册资本相应减少。本次变动因公司于2026年6月22日购回并注销1,148,700股H股所致,资金来源为自有资金,已获董事会及股东大会授权批准。A股普通股注册股本无变动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688366","BK0251","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648645646","title":"昊海生科(688366)披露H股股份注销公告,7月3日股价上涨1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648645646","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648645646?lang=zh_cn&edition=full","pubTime":"2026-07-03 22:57","pubTimestamp":1783090634,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,昊海生科报收于31.04元,较前一交易日上涨1.27%,最新总市值为71.03亿元。该股当日开盘30.65元,最高31.17元,最低30.51元,成交额达2097.97万元,换手率为0.35%。近日,昊海生科披露《截至二零二六年六月三十日止月份股份发行人的证券变动月报表》。公告显示,截至2026年6月30日,公司H股普通股注册股本由上月底35,929,040股减少至34,780,340股,注册资本相应减少1,148,700元人民币。公司确认已符合香港联交所规定的公众持股量要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300046151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0239","688366"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646231529","title":"每周股票复盘:昊海生科(688366)注销114.87万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646231529","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646231529?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:43","pubTimestamp":1782589390,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,昊海生科报收于28.61元,较上周的30.15元下跌5.11%。本周,昊海生科6月24日盘中最高价报31.9元。本周关注点公司公告汇总:昊海生科完成注销1,148,700股H股股份,总股本由229,980,895股变更为228,832,195股。公司公告汇总上海昊海生物科技股份有限公司于2026年3月23日至5月15日期间实际回购H股股份1,148,700股,占公司总股本的0.50%,使用资金总额2,547.1688万港元。A股股份占比由84.38%上升至84.80%,H股股份占比由15.62%下降至15.20%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800001161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0251","688366"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646366535","title":"昊海生科(688366)披露关于变更持续督导保荐代表人的公告,6月26日股价下跌3.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646366535","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646366535?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:55","pubTimestamp":1782485717,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,昊海生科报收于28.61元,较前一交易日下跌3.57%,最新总市值为65.47亿元。该股当日开盘28.97元,最高29.97元,最低28.61元,成交额达1535.83万元,换手率为0.27%。近日,上海昊海生物科技股份有限公司发布《关于变更持续督导保荐代表人的公告》。公告显示,公司接到瑞银证券通知,原持续督导保荐代表人孙利军因工作变动不再担任相关职务,由王依诺接任。公司对孙利军任职期间的贡献表示感谢。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600046099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688366","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644931743","title":"执行董事唐敏捷增持昊海生科(06826)5000股 每股作价16.12港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644931743","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644931743?lang=zh_cn&edition=full","pubTime":"2026-06-17 19:02","pubTimestamp":1781694143,"startTime":"0","endTime":"0","summary":"香港联交所最新数据显示,6月16日,执行董事唐敏捷增持昊海生科(06826)5000股,每股作价16.12港元,总金额约为8.06万港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260617/20260617190330_44960.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260617/20260617190330_44960.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455676.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","BK0251","BK1161","688366","EWH","BK1593","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640158880","title":"港股异动 | 昊海生科(06826)尾盘涨近3% 控股子公司三焦点人工晶状体产品获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2640158880","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640158880?lang=zh_cn&edition=full","pubTime":"2026-06-04 15:54","pubTimestamp":1780559657,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,昊海生科尾盘涨近3%,截至发稿,涨2.87%,报17.87港元,成交额411.34万港元。消息面上,昊海生科公告称,其控股子公司赛美视自主研发的三焦点人工晶状体获得国家药品监督管理局的注册批准。该人工晶状体用于植入囊袋内。该产品是公司本年度获批的又一款多焦点人工晶状体产品,不仅加速并完善了公司在高端多焦点人工晶状体领域的布局,更为眼科业务的发展注入了新动能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450077.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK4588","BK4585","BK1100","BK0251","VXUS","BK1583","688366","09996","06826","BK1161","BK1593","159883","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640591084","title":"昊海生科(688366.SH)控股子公司三焦点人工晶状体产品获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2640591084","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640591084?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:35","pubTimestamp":1780400126,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昊海生科 发布公告,公司控股子公司河南赛美视生物科技有限公司于近日收到国家药品监督管理局颁发的关于三焦点人工晶状体产品的《中华人民共和国医疗器械注册证》。该人工晶状体用于植入囊袋内。该产品是公司本年度获批的又一款多焦点人工晶状体产品,不仅加速并完善了公司在高端多焦点人工晶状体领域的布局,更为眼科业务的发展注入了新动能。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","09996","BK1100","BK1583","BK1574","BK0239","688366","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640995802","title":"昊海生科(688366)披露因H股股份回购需通知债权人公告,6月1日股价上涨0.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640995802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640995802?lang=zh_cn&edition=full","pubTime":"2026-06-01 18:15","pubTimestamp":1780308955,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘,昊海生科报收于34.8元,较前一交易日上涨0.99%,最新总市值为80.03亿元。该股当日开盘34.32元,最高34.85元,最低33.77元,成交额达1913.49万元,换手率为0.29%。近日,上海昊海生物科技股份有限公司发布《因H股股份回购需通知债权人公告》。回购期限至2026年年度股东会结束或特别决议撤销授权之日止。回购完成后将注销股份并减少注册资本。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100029616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688366","BK0251","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187483906","title":"昊海生科:侯永泰辞任执行董事、董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=1187483906","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187483906?lang=zh_cn&edition=full","pubTime":"2026-05-29 22:18","pubTimestamp":1780064301,"startTime":"0","endTime":"0","summary":"昊海生科宣布,侯永泰先生已向公司董事会提交辞呈,辞去其担任的执行董事及董事长职务。公司董事会将依据相关法律法规及公司章程的规定,尽快启动新任董事长的选举程序,并确保公司治理结构的平稳过渡与日常运营的持续稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688366","BK0239","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638378315","title":"5月25日昊海生科发布公告,股东减持77.47万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638378315","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638378315?lang=zh_cn&edition=full","pubTime":"2026-05-25 19:01","pubTimestamp":1779706871,"startTime":"0","endTime":"0","summary":"证券之星消息,5月25日昊海生科发布公告《昊海生科:上海昊海生物科技股份有限公司股东减持股份结果公告》,其股东楼国梁于2026年2月26日至2026年5月25日间合计减持77.47万股,占公司目前总股本的0.3369%,变动期间该股股价下跌25.7%,截止5月25日收盘报34.41元。股东增减持详情见下表:根据昊海生科2026年一季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500026908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688366","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636062967","title":"每周股票复盘:昊海生科(688366)累计购回374.89万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636062967","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636062967?lang=zh_cn&edition=full","pubTime":"2026-05-17 04:29","pubTimestamp":1778963349,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,昊海生科报收于36.82元,较上周的39.14元下跌5.93%。本周,昊海生科5月12日盘中最高价报39.99元。本周关注点公司公告汇总:昊海生科自2026年3月23日至5月15日累计购回3,748,900股H股,占决议通过当日已发行股份的9.4858%。H股公告:翌日披露报表上海昊海生物科技股份有限公司于2026年5月13日提交翌日披露报表,显示当日购回31,500股H股,每股价格介乎22.08至22.46港元,总代价为703,288港元。本次购回后30日内不得发行新股或出售库存股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688366","BK0239","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635035835","title":"昊海生科(688366)披露H股股份购回进展,5月15日股价下跌1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635035835","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635035835?lang=zh_cn&edition=full","pubTime":"2026-05-15 22:53","pubTimestamp":1778856790,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,昊海生科报收于36.82元,较前一交易日下跌1.07%,最新总市值为84.68亿元。该股当日开盘37.36元,最高37.67元,最低36.56元,成交额达2598.52万元,换手率为0.36%。近日,昊海生科披露H股股份购回进展公告。截至2026年5月15日,公司已发行H股股份总数仍为35,929,040股。购回授权于2025年6月10日获决议通过,可购回股份总数为3,914,184股,目前已购回3,748,900股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500044488.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688366","BK0251","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635702143","title":"昊海生科风波再起:实控人涉嫌内幕交易,业绩断崖式下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2635702143","media":"新浪证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635702143?lang=zh_cn&edition=full","pubTime":"2026-05-15 16:56","pubTimestamp":1778835360,"startTime":"0","endTime":"0","summary":" 昊海生科近日公告,公司实际控制人之一蒋伟因涉嫌内幕交易被上海市公安局取保候审,期限自2026年4月29日起算。这已是蒋伟第二次因同一性质事件进入监管视野——2025年12月,证监会已就其内幕交易及建议他人买卖证券行为作出处罚,没收违法所得并罚款合计超过1900万元。公告发布当日,公司A股及H股双双收跌,显示出市场对实控人涉案的担忧并未消除。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-05-15/doc-inhxyimh8168674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688366","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786695894144,"stockEarnings":[{"period":"1week","weight":0.0621},{"period":"1month","weight":0.0261},{"period":"3month","weight":-0.0859},{"period":"6month","weight":-0.2669},{"period":"1year","weight":-0.3901},{"period":"ytd","weight":-0.2333}],"compareEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":-0.0101},{"period":"3month","weight":-0.0504},{"period":"6month","weight":-0.038},{"period":"1year","weight":0.0661},{"period":"ytd","weight":-0.0106}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海昊海生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2019-10-30","address":"上海市松江区松江工业区洞泾路5号","registeredCapital":"22883万元","survey":" 上海昊海生物科技股份有限公司的主营业务是医疗器械和药品研发、生产和销售业务。公司的主要产品是医疗美容与创面护理产品、眼科产品、骨科关节腔粘弹补充剂产品、防粘连及止血产品。本集团的医用几丁糖专利技术先后获得“上海市技术发明一等奖”和“国家科学技术进步奖二等奖”,生产出国际上第一个成功应用于人体内的医用几丁糖产品;外用人表皮生长因子产品获得“国家科学技术进步奖二等奖”,是国际第一个获得注册的外用人表皮生长因子产品;本集团参与研发的“生物适配防粘连材料的关键技术及临床应用”项目获得上海市技术发明奖一等奖。","listedPrice":89.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昊海生科(688366)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昊海生科(688366)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昊海生科,688366,昊海生科股票,昊海生科股票老虎,昊海生科股票老虎国际,昊海生科行情,昊海生科股票行情,昊海生科股价,昊海生科股市,昊海生科股票价格,昊海生科股票交易,昊海生科股票购买,昊海生科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昊海生科(688366)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昊海生科(688366)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}